https://www.selleckchem.com/pr....oducts/gilteritinib-
However, use of non-pharmacological treatment in the past was uniquely predictive of its re-use in the present and future. This pattern was also accounted for by individual differences in pain magnification and wellbeing in the past. CONCLUSIONS Treatment preferences of FM individuals reveal an ambivalent combination of heavy reliance on pharmacological treatment with lower but consistent reliance on non-pharmacological treatment for those individuals who used it in the past and present. This finding may inform longitudinal
Like
Comment
Share
